loading...| Preferred Name |
maprotiline |
|
| Synonyms |
methyl(3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl}propyl)amine C20H23N |
|
| ID |
http://purl.obolibrary.org/obo/dinto_DB00934 |
|
| AHFScode |
28:16.04.28 |
|
| ATCCode |
N06AA21 |
|
| blocks |
http://purl.obolibrary.org/obo/dinto_3182 http://purl.obolibrary.org/obo/dinto_1005 http://purl.obolibrary.org/obo/dinto_0703 http://purl.obolibrary.org/obo/dinto_3887 http://purl.obolibrary.org/obo/dinto_1071 |
|
| CASRN |
10262-69-8 |
|
| DBBrand |
psymion deprilept ludiomil |
|
| DBSynonym |
maprotilina [inn-spanish] maprotiline hcl maprotylina [polish] maprotilinum [inn-latin] |
|
| Definition |
Maprotiline is a tetracyclic antidepressant with similar pharmacological properties to tricyclic antidepressants (TCAs). Similar to TCAs, maprotiline inhibits neuronal norepinephrine reuptake, possesses some anticholinergic activity, and does not affect monoamine oxidase activity. It differs from TCAs in that it does not appear to block serotonin reuptake. Maprotiline may be used to treat depressive affective disorders, including dysthymic disorder (depressive neurosis) and major depressive disorder. Maprotiline is effective at reducing symptoms of anxiety associated with depression. |
|
| has pharmacological target | ||
| InChI |
InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3 |
|
| InChIKey |
InChIKey=QSLMDECMDJKHMQ-UHFFFAOYSA-N |
|
| inhibits | ||
| is metabolised by | ||
| label |
maprotiline |
|
| may interact with |
http://purl.obolibrary.org/obo/CHEBI_32250 http://purl.obolibrary.org/obo/CHEBI_9943 http://purl.obolibrary.org/obo/CHEBI_8499 http://purl.obolibrary.org/obo/CHEBI_156095 http://purl.obolibrary.org/obo/CHEBI_42944 http://purl.obolibrary.org/obo/dinto_DB00209 http://purl.obolibrary.org/obo/dinto_DB00857 http://purl.obolibrary.org/obo/CHEBI_8874 http://purl.obolibrary.org/obo/CHEBI_61049 http://purl.obolibrary.org/obo/dinto_DB00726 http://purl.obolibrary.org/obo/CHEBI_53289 http://purl.obolibrary.org/obo/CHEBI_6780 http://purl.obolibrary.org/obo/CHEBI_9566 http://purl.obolibrary.org/obo/CHEBI_51364 http://purl.obolibrary.org/obo/CHEBI_9654 http://purl.obolibrary.org/obo/dinto_DB00582 http://purl.obolibrary.org/obo/dinto_DB00427 http://purl.obolibrary.org/obo/CHEBI_10119 http://purl.obolibrary.org/obo/CHEBI_9635 http://purl.obolibrary.org/obo/CHEBI_3720 http://purl.obolibrary.org/obo/CHEBI_27796 http://purl.obolibrary.org/obo/dinto_DB00752 http://purl.obolibrary.org/obo/CHEBI_45716 http://purl.obolibrary.org/obo/dinto_DB00382 http://purl.obolibrary.org/obo/CHEBI_10124 http://purl.obolibrary.org/obo/CHEBI_195280 |
|
| prefixIRI |
obo2:dinto_DB00934 |
|
| prefLabel |
maprotiline |
|
| related with | ||
| SMILES |
CNCCCC12CCC(C3=CC=CC=C13)C1=CC=CC=C21 |
|
| Synonym |
methyl(3-{tetracyclo[6.6.2.0^{2,7}.0^{9,14}]hexadeca-2(7),3,5,9(14),10,12-hexaen-1-yl}propyl)amine C20H23N |
|
| xref |
IUPHAR:2402 BindingDB:35228 Guide To Pharmacology:2402 National Drug Code Directory:0378-0060-01 Wikipedia:http://en.wikipedia.org/wiki/Maprotiline PubChem Compound:4011 ChemSpider:3871 Drugs.com:http://www.drugs.com/cdi/maprotiline.html PubChem Substance:46508358 PharmGKB:PA450322 |
|
| subClassOf |